EQUITY AWARDS (Tables)

3 Months Ended

Mar. 31, 2021

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the three months ended March 31, 2021 and 2020 follows:

Three Months Ended March 31, 2021	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		506,200		$	26.81		5.82	$	1,805
Effect of 10% stock dividend		50,770
Granted		24,500			33.37		9.86		83
Exercised		(24,250	)		21.74		3.28		364
Forfeited		(10,000	)		28.54		5.97		82
Balance, March 31, 2021		547,220		$	24.81		5.88	$	6,532
Exercisable at end of period		296,922		$	23.49		4.64	$	3,938

Three Months Ended March 31, 2020	Number of Shares			Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Outstanding at beginning of year		508,000		$	26.68		6.24	$	3,159
Granted		23,000			29.00		9.84		11
Exercised		(3,000	)		24.00		2.54		—
Forfeited		(24,400	)		31.72		8.46		—
Balance, March 31, 2020		503,600		$	26.55		6.07	$	21
Exercisable at end of period		260,880		$	25.26		5.01	$	7

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the three months ended March 31, 2021 and 2020 follows:

Three Months Ended March 31, 2021	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		214,680		$	4.46
Effect of 10% stock dividend		23,218
Granted		24,500			5.67
Vested		(12,100	)		(4.59	)
Forfeited		—			—
Balance, March 31, 2021		250,298		$	5.11

Three Months Ended March 31, 2020	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		251,120		$	4.97
Granted		23,000			5.62
Vested		(8,200	)		(5.18	)
Forfeited		(23,200	)		(1.93	)
Balance, March 31, 2020		242,720		$	5.90

Plan Information

Information related to stock options in the Plan is as follows for the three months ended:

	March 31, 2021		March 31, 2020
Intrinsic value of options exercised	$	364	$	—
Cash received from options exercised		527		72
Weighted average fair value of options granted		5.67		5.62

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the three months ended March 31, 2021 and 2020 follows:

Three Months Ended March 31, 2021	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		35,300		$	29.72
Effect of 10% stock dividend		3,530			—
Granted		—			—
Vested		(4,840	)		30.25
Forfeited		—			—
Balance, March 31, 2021		33,990		$	26.95

Three Months Ended March 31, 2020	Number of Shares			Weighted-Average Grant Date Fair Value
Outstanding at beginning of year		31,459		$	30.29
Granted		—			—
Vested		(6,100	)		30.25
Forfeited		—			—
Balance, March 31, 2020		25,359		$	30.29